International physician survey on management of FOP: a modified Delphi study

Abstract Fibrodysplasia ossificans progressiva (FOP), a disabling disorder of progressive heterotopic ossification (HEO), is caused by heterozygous gain-of- function mutations in Activin receptor A, type I (ACVR1, also known as ALK2), a bone morphogenetic protein (BMP) type I receptor. Presently, sy...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Maja Di Rocco, Genevieve Baujat, Marta Bertamino, Matthew Brown, Carmen L. De Cunto, Patricia L. R. Delai, Elisabeth M. W. Eekhoff, Nobuhiko Haga, Edward Hsiao, Richard Keen, Rolf Morhart, Robert J. Pignolo, Frederick S. Kaplan
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2017-06-01
Edice:Orphanet Journal of Rare Diseases
Témata:
Fibrodysplasia ossificans progressiva
ACVR1
On-line přístup:http://link.springer.com/article/10.1186/s13023-017-0659-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky